In a study, monthly blood testing vs testing every 6 weeks was not associated with a lower risk of death among prevalent and incident hemodialysis (HD) patients, but is associated with an increased risk of hyperkalemia, cardiovascular events, and all-cause hospitalization among incident HD patients.
Intradialytic hypotension (IDH) occurring in 30% or more of hemodialysis sessions is associated with a 36% increased likelihood of peripheral artery disease compared with no IDH, according to a new study.
In a study, frail patients had about twice the risk for prolonged recovery from hemodialysis than non-frail patients, who appear to have more resiliency.
In a study of hemodialysis patients, hypercalcemia accompanied by high parathyroid hormone levels was associated with nearly 2.6-fold increased odds of intradialytic hypotension.
Many nephrologists and other healthcare providers (HCPs) have enthusiastically embraced the July 10 presidential executive order titled, “Advancing American Kidney Health Initiative.” The 3 main components include a reduction in the end-stage renal disease (ESRD) rate by 25% by 2030; a substantial increase in home dialysis so that 80% of new ESRD patients can receive…
